#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12860	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2174	588.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1725	1725	T	656	T	613	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12860	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2174	588.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1459	1459	C	764	C	717	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23354	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3424	679.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1584	1584	A	788	A,G	736,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23354	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3424	679.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2218	2218	C	765	C	709	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23354	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3424	679.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2292	2292	A	785	A	736	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23354	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3424	679.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2844	2844	C	710	C,A,G	666,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	79680	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1562	5062.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1868	folP	855	855	99.88	folP.l15.c4.ctg.1	1442	128.7	1	SNP	p	R229S	1	.	.	685	687	AGC	954	956	AGC	214;217;219	A;G;C,T	194;196;196,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4558	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3358	135.4	0	.	p	.	0	D95A	NONSYN	283	285	GAC	559	561	GCC	154;154;156	G;C;C	146;145;148	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4558	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3358	135.4	1	SNP	p	S91F	1	.	.	271	273	TTC	547	549	TTC	156;157;157	T;T;C	146;146;146	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1492	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1299	114.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	445	447	ACC	197;198;200	A,G;C;C,A	175,3;179;177,2	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1492	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1299	114.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	643	645	CAC	187;190;190	C;A;C	173;175;178	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1492	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1299	114.4	0	.	p	.	0	A127fs	FSHIFT	379	379	G	709	709	G	197	G	183	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1492	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1299	114.4	1	SNP	p	G45D	0	.	.	133	135	GGC	463	465	GGC	200;201;200	G;G,A;C	182;183,1;184	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	792	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	959	81.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4182	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3074	135.7	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1556	1558	GTC	161;158;157	G;T;C,T	151;148;147,1	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4182	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3074	135.7	1	SNP	p	D86N	0	.	.	256	258	GAC	662	664	GAC	170;170;174	G;A;C	160;154;164	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4182	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3074	135.7	1	SNP	p	R87I	0	.	.	259	261	CGT	665	667	CGT	173;176;177	C,A;G;T	163,1;166;166	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4182	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3074	135.7	1	SNP	p	S87R	1	.	.	259	261	CGT	665	667	CGT	173;176;177	C,A;G;T	163,1;166;166	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4182	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3074	135.7	1	SNP	p	R87W	0	.	.	259	261	CGT	665	667	CGT	173;176;177	C,A;G;T	163,1;166;166	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4182	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3074	135.7	1	SNP	p	S88P	0	.	.	262	264	TCC	668	670	TCC	174;176;177	T;C;C	164;167;169	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3926	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2610	149.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1508	1510	GGC	207;208;206	G;G;C	192;193;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1287	1289	GCA	185;188;188	G;C;A	173;175;181	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1290	1292	ATC	186;186;187	A;T;C	178;178;181	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1302	1304	GTG	197;196;197	G;T;G	187;183;185	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1302	1304	GTG	197;196;197	G;T;G	187;183;185	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1806	1808	ACC	196;195;200	A;C;C	178;182;187	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1860	1862	GCG	205;202;205	G;C,A;G	169;156,1;171	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1860	1862	GCG	205;202;205	G;C,A;G	169;156,1;171	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1983	1985	GGT	179;177;173	G;G;T	163;160;159	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1992	1994	GGC	165;164;161	G;G;C	157;155;150	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	144.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2010	2012	CCG	160;160;159	C,G;C;G	114,1;123;120	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5026	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3008	166.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1529	1531	CCG	210;207;204	C,G;C;G,C	183,1;188;178,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2090	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1937	107.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	634	634	C	143	C	135	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2638	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1497	174.3	0	.	p	.	0	R143G	NONSYN	427	429	AGA	674	676	GGA	217;219;219	G;G;A	196;199;194	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2638	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1497	174.3	0	.	p	.	0	.	INDELS	629	630	AA	877	879	TAG	218;216;211	T;A;G	195;196;191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2638	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1497	174.3	0	.	p	.	0	.	MULTIPLE	631	633	TAC	881	884	CAAT	209;208;206;204	C;A;A;T	190;191;189;189	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2638	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1497	174.3	0	.	p	.	0	N212fs	FSHIFT	634	634	A	886	886	T	206	T	191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2638	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1497	174.3	1	SNP	p	G120K	0	.	.	358	360	GGT	605	607	GGT	204;203;201	G;G;T	189;188;186	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2638	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1497	174.3	1	SNP	p	A121D	0	.	.	361	363	GCC	608	610	GCC	199;197;201	G;C;C	185;185;190	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2638	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1497	174.3	1	SNP	p	A121N	0	.	.	361	363	GCC	608	610	GCC	199;197;201	G;C;C	185;185;190	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9928	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4858	203.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2064	2066	AAT	232;233;238	A;A;T	212;213;219	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1166	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	952	121.3	1	SNP	p	V57M	1	.	.	169	171	ATG	478	480	ATG	256;257;259	A;T;G	241;240;243	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	M177T	NONSYN	529	531	ATG	868	870	ACG	454;452;452	A,G;C;G,T	431,1;434;434,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	889	891	GAC	398;395;393	G;A;C	397;389;388	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	T190M	NONSYN	568	570	ACG	907	909	ATG	399;400;399	A;T;G	397;396;397	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	L194S	NONSYN	580	582	TTA	919	921	TCA	384;379;375	T;C;A,G	380;376;369,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	964	966	CAG	411;410;409	C;A;G	408;406;406	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	V216L	NONSYN	646	648	GTT	985	987	CTT	387;386;387	C,T;T;T	384,1;384;384	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1006	1008	AGT	389;394;398	A;G;T	375;378;380	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1075	1077	CCG	586;590;599	C;C;G	552;554;564	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1177	1179	TCG	598;599;597	T,C;C;G	554,1;554;553	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1348	1350	AAA	336;330;324	A;A;A	320;315;311	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1351	1353	AAG	314;315;309	A;A;G	303;305;298	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1366	1368	CAC	283;285;281	C;A,T;C	280;270,1;280	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1405	1407	GAA	247;246;245	G,C;A;A	246,1;246;245	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1483	1485	ACG	179;177;178	A,G;C;G	174,1;175;177	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1534	1536	ATT	254;255;256	A;T,C;T	232;229,2;234	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1537	1539	AGT	252;251;251	A,T;G;T	231,1;230;229	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1576	1578	CTA	269;269;270	C;T;A	247;250;253	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1618	1620	AAT	188;189;190	A;A;T	178;180;179	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1687	1689	TCA	281;280;283	T;C;A	271;270;271	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1711	1713	ATG	299;297;298	A;T;G	287;283;286	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2005	2007	ACC	682;677;677	A;C;C	629;629;625	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11442	tetM	1920	1920	96.3	tetM.l6.c30.ctg.1	2683	425.1	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2101	2103	GAA	634;633;631	G,A;A;A	589,1;592;590	.	Tetracycline resistance
